Business Wire

Business Wire is the global leader in news release distribution and regulatory disclosure. Business Wire delivers news and multimedia directly into editorial systems and leading online news platforms and is a trusted source for news organisations, journalists, investment professionals and regulatory authorities.

Results: 5473-5484 of 22650

Erik Todd, Chief Executive Officer of Swan EndoSurgical, Inc.

Swan EndoSurgical Appoints Veteran Robotics and MedTech Leader Erik Todd as Chief Executive Officer

Invisible IT Emerges as Workplace Transformation Evolves, Lenovo Research Finds

Wasabi Launches Covert Copy, a Completely Invisible and Indestructible Copy of Data for a Higher Level of Cloud Storage Security

Aquila Air Capital Opens New Headquarters in Dublin, Ireland

CorriXR Therapeutics, InhaTarget Therapeutics, and Merxin Ltd Announce Strategic Collaboration for the Development of Inhaled Lung Cancer Treatment

Luma AI Opens for International Business With Former WPP Executive Jason Day Leading New London Office

Aurigene Oncology Limited Announces Encouraging Initial Data From 1st Two Cohorts of Phase 1 Study of AUR112, an Oral Small Molecule Inhibitor of MALT1, in Relapsed/Refractory Lymphoid Malignancies

Business Wire

Swan EndoSurgical Appoints Veteran Robotics and MedTech Leader Erik Todd as Chief Executive Officer

Invisible IT Emerges as Workplace Transformation Evolves, Lenovo Research Finds

Wasabi Launches Covert Copy, a Completely Invisible and Indestructible Copy of Data for a Higher Level of Cloud Storage Security

Aquila Air Capital Opens New Headquarters in Dublin, Ireland

CorriXR Therapeutics, InhaTarget Therapeutics, and Merxin Ltd Announce Strategic Collaboration for the Development of Inhaled Lung Cancer Treatment

Luma AI Opens for International Business With Former WPP Executive Jason Day Leading New London Office

Aurigene Oncology Limited Announces Encouraging Initial Data From 1st Two Cohorts of Phase 1 Study of AUR112, an Oral Small Molecule Inhibitor of MALT1, in Relapsed/Refractory Lymphoid Malignancies

AdvanCell Initiates Phase 2 Expansion Trial of ADVC001, a Novel Targeted Alpha Therapy for Prostate Cancer

Eventbrite Enters into Definitive Agreement to Be Acquired by Bending Spoons for Roughly $500 Million to Accelerate Eventbrite’s Next Phase of Growth

ICON Survey Reveals Increasing Clinical Trial Startup Delays, Underscoring Need for Human-Centred Site Activation Solutions

Armis Recognized for Innovation; Named to Inc. Best in Business List for the Second Consecutive Year

CI Financial Corp. Announces Private Offering of Euro Notes